New Metric for Acute Cough Prognosis Tested by Researchers

Importance of Acute Cough in Primary Care

Researchers have recently evaluated a novel metric for predicting the prognosis of acute cough and assessed its effectiveness compared to existing metrics. Acute cough is a significant symptom that leads many individuals to seek assistance from primary care physicians. In Europe, it is estimated that 30 to 50 patients per 1,000 experience acute cough annually, despite the availability of various antibiotics for the infections that cause it.

Antibiotic Prescription Considerations

The research underscores the necessity for health professionals to consider the potential complications associated with antibiotic prescriptions on a case-by-case basis. It is crucial to carefully weigh treatment options to justify the use of these medications.

Metrics for Acute Cough Prognosis

Existing Prognostic Metrics

Several metrics are currently utilized to evaluate the prognosis of patients with acute cough, including:

– Pneumonia Severity Index (PSI)
– CRB (Confusion, Respiratory Rate, Blood Pressure)
– CURB (Confusion, Urea Nitrogen, Respiratory Rate, Blood Pressure)
– CRB-65 (for patients aged 65 and older)
– CURB-65

These tools assess the likelihood of adverse outcomes for both inpatients and outpatients suffering from lower respiratory infections. However, due to the low mortality rate associated with these conditions, researcher Robin Bruyndonckx and his team sought to establish a new metric to better interpret acute cough prognosis.

Development of a New Prognostic Metric

Study Design and Data Collection

The research team gathered data from 2,604 adults participating in the Genomics to Combat Resistance against Antibiotics in Community-acquired LRTI in Europe (GRACE) network. Eligible participants exhibited either acute cough or symptoms indicative of a lower respiratory tract infection.

Comparative Analysis of Metrics

To evaluate the new metric’s predictive ability for poor outcomes in acute cough patients, the researchers compared it with existing prognostic tools. They also assessed additional tests, including C-reactive protein (CRP), blood urea nitrogen (BUN), and chest radiography. CRP levels surge during acute infections and inflammatory conditions, while BUN measures kidney function, and chest radiography helps identify any complications.

New Prediction Metric Shows Superior Performance

Study Findings

Results published in the British Journal of General Practice indicated that the newly developed prediction metric surpassed all previous metrics, proving to be a valuable tool for healthcare professionals in everyday prognosis of acute cough patients. The significance of these findings was amplified when it was shown that the additional tests used to assess patient outcomes were rendered unnecessary in light of this new prognostic system.

Future Implications for Healthcare Practice

Before the new metric can be integrated into clinical practice, further studies are required to confirm its effectiveness in enhancing patient management, including minimizing adverse side effects. Nonetheless, this metric holds the potential to assist general practitioners in accurately determining the necessity of antibiotic prescriptions, thereby reducing the incidence of over-prescription.

Authorship and Reference

Written by Dr. Apollina Sharma, MBBS, GradDip EXMD.

Reference: Bruyndonckx, R., Hens, N., Verheij, T. J., Aerts, M., Ieven, M., Butler, C. C., … & GRACE project group. (2018). Development of a prediction tool for patients presenting with acute cough in primary care: a prognostic study spanning six European countries. Br J Gen Pract, bjgp18X695789.